Skip to main content

JPMORGAN CHASE & CO

Position in CTMX — CytomX Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in CTMX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$410,297
+$265,815 QoQ
Shares Held
109,413
+255.9% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 178 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. CTMX ranks #205 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $410,297 109,413
2026-03-31 $144,482 30,741
2025-12-31 $103,786 24,363
2025-09-30 $51,524 16,152
2025-06-30 $637 281
2025-03-31 $66,966 105,294
2024-12-31 $835,978 811,630
2024-09-30 $331 281
2024-06-30 $342 281
2024-03-31 $612 281
2023-12-31 $435 281
2023-09-30 $2,231 1,730
2023-06-30 $2,975 1,730
2023-03-31 $2,612 1,730
2022-12-31 $2,768 1,730
2022-09-30 $6,382 4,402
2022-06-30 $5,447 2,977
2022-03-31 $814,434 305,032
2021-12-31 $1,330,300 307,229
2021-09-30 $1,630,153 320,266
2021-06-30 $2,161,916 341,535
2021-03-31 $558,152 72,206
2020-12-31 $527,430 80,524
2020-09-30 $613,827 92,305
2020-06-30 $829,499 99,580
2020-03-31 $1,350,018 176,013